Wednesday 3 July 2024

The Pharma Letter Podcast — Episode 1 — Belong.Life

Pharmaceutical
Simon Wentworth
13 July 2021
podcast-episode1-1--1

More on this story...

Pharmaceutical
Time for digital marketing of migraine drugs has arrived in Japan
8 July 2021
Pharmaceutical
Manufacturing and marketing approval in Japan for Joyclu
25 March 2021
Pharmaceutical
Exec change at Merck, as Mike Nally quits top marketing job
18 March 2021
Biotechnology
The Pharma Letter Podcast — Episode 4 — The state of biotech investing
1 September 2021


More ones to watch >


Today's issue

Pharmaceutical
Access to medicines key to British voters, survey shows
3 July 2024
Generics
US authorities clear Mylan in long-running antitrust probe
3 July 2024
Biotechnology
Touchlight and LeninBio announce link up
3 July 2024
Pharmaceutical
Pentixapharm pads pipeline with strategic acquisition
3 July 2024
Biotechnology
Beacon Therapeutics raises $170 million in a Series B financing
3 July 2024
Biotechnology
Lilly's Alzheimer’s drug Kisunla wins FDA approval
3 July 2024
Biotechnology
First COPD nod could add billions to Dupixent revenue
3 July 2024

Company Spotlight

A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.




More Features in Pharmaceutical

Access to medicines key to British voters, survey shows
3 July 2024
Pentixapharm pads pipeline with strategic acquisition
3 July 2024
Striking results in Phase III Parkinson’s trial
3 July 2024
ThirtyFiveBio receives grant to continue work on GPR35 blockers
2 July 2024


Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze